West Pharmaceutical Services

Profile narrative

West Pharmaceutical Services provides pharmaceutical packaging and drug delivery solutions, serving the global healthcare industry. The company designs and manufactures components such as stoppers, seals, plungers, and delivery devices that are used in injectable drug products. These components are essential for maintaining sterility, stability, and patient safety throughout the product lifecycle. West Pharmaceutical Services supplies its products to pharmaceutical and biotechnology companies across multiple regions, offering both standard catalog items and custom‑engineered solutions tailored to specific drug formulations. Its expertise supports the manufacturing processes of clients who rely on reliable containment and delivery systems for a wide range of therapeutics.

Headquartered in the United States, West Pharmaceutical Services maintains a global footprint, as demonstrated by the worldwide impact of the 2026 cyber incident on its pharmaceutical packaging and drug delivery supply chain operations. The intrusion prompted a coordinated international response, including the engagement of external cybersecurity experts from Palo Alto Networks Unit 42, the activation of crisis management protocols, and notification of law enforcement agencies. This response reflects the company’s sizable enterprise structure with distributed manufacturing, logistics, and administrative sites across various countries. While specific employee counts or revenue figures are not disclosed in the available sources, the ability to disrupt operations on a global scale indicates a substantial international presence and a complex operational network.

West Pharmaceutical Services specializes in containment and delivery systems for parenteral medications, a niche that demands strict adherence to regulatory standards set by agencies such as the FDA and EMA. The company’s deep expertise in material science and precision manufacturing allows it to produce components that preserve drug integrity from production through patient administration. Its positioning as a critical supplier in the pharmaceutical packaging sector is highlighted by its role in supporting essential shipping, receiving, and manufacturing processes for drug makers worldwide. The 2026 incident also revealed a mature crisis management capability, as the organization swiftly enlisted specialized incident response partners, restricted access to enterprise systems, and worked to restore core operations while investigating the extent of data exfiltration.

No explicit information about ownership, parent company, or subsidiary relationships is provided in the source material, so this aspect is omitted from the profile.

Incidents

1 incident linked to this organisation.